Process Industries
Asahi Kasei Corp.
In the news
- Nobel boost: Battery stocks surge following Yoshino win Oct 11, 2019
- Nobel laureate Yoshino created the rechargeable world we live in Oct 10, 2019
- Japan's Yoshino wins Nobel for lithium-ion battery breakthrough Oct 10, 2019
- Toray plans European factory for electric-car battery separators Jul 13, 2019
- South Korea threatens retaliation over Japan export controls Jul 5, 2019 See more articles on Asahi Kasei Corp.
Business Summary
Asahi Kasei Corp. operates as a holding company which provides monitoring, planning, and strategic management to its subsidiaries and affiliates. Its operations are carried out through the following segments: Materials, Homes, Health Care, and Others. The Materials segment includes caustic soda, chlorine, acrylonitrile, styrene, methyl methacrylate, adipic acid, polyethylene, polystyrene, and other petrochemicals. The Homes segment includes "Long Life Home" products and also provides remodeling, real estate, and urban redevelopment. The Health Care segment includes pharmaceuticals and diagnostic reagents. The Others segment includes engineering, employment agency and temporary staffing services. The company was founded on May 21, 1931 and is headquartered in Tokyo, Japan.
Financial Highlights
| Mar 2019 | JPY | USD |
| Revenue | 2,170.40B | 19,571.75M |
| Gross Profit | 715,748M | 6,454.30M |
| Operating income | 209,588M | 1,889.97M |
| Income before tax | 210,397M | 1,897.26M |
| Net income | 147,512M | 1,330.19M |
| EBITDA | 313,634M | 2,828.21M |
| Diluted EPS | 105.65 | 0.95 |
| Dividends Per Share | 34 | 0.30 |
| Total Assets | 2,575.20B | 23,266.05M |
| Total liabilities | 1,172.49B | 10,593.05M |
| Total equity | 1,381.48B | 12,481.23M |
| Operating cash flow | 212,062M | 1,912.28M |
| Currency in JPY | Currency in USD |
Historical Data
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
| Revenue | 1,986.40B | 1,940.91B | 1,882.99B | 2,042.21B | 2,170.40B |
| Gross Profit | 564,705M | 606,344M | 606,826M | 672,802M | 715,748M |
| Operating income | 157,933M | 165,203M | 159,230M | 198,475M | 209,588M |
| Income before tax | 158,440M | 146,389M | 157,388M | 218,333M | 210,397M |
| Net income | 105,652M | 91,754M | 115,000M | 170,249M | 147,512M |
| EBITDA | 253,311M | 274,835M | 268,423M | 311,938M | 313,634M |
| Diluted EPS | 75.62 | 65.69 | 82.34 | 121.92 | 105.65 |
| Dividends Per Share | 19 | 20 | 24 | 34 | 34 |
| Total Assets | 2,014.53B | 2,211.72B | 2,254.50B | 2,307.15B | 2,575.20B |
| Total liabilities | 916,809M | 1,154.33B | 1,086.38B | 1,001.93B | 1,172.49B |
| Total equity | 1,082.65B | 1,041.90B | 1,151.34B | 1,287.38B | 1,381.48B |
| Operating cash flow | 137,597M | 216,218M | 168,965M | 249,891M | 212,062M |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
| Revenue | 18,081.81M | 16,162.93M | 17,388.81M | 18,426.16M | 19,571.75M |
| Gross Profit | 5,140.38M | 5,049.32M | 5,603.84M | 6,070.44M | 6,454.30M |
| Operating income | 1,437.63M | 1,375.72M | 1,470.43M | 1,790.76M | 1,889.97M |
| Income before tax | 1,442.24M | 1,219.05M | 1,453.42M | 1,969.93M | 1,897.26M |
| Net income | 961.72M | 764.07M | 1,061.98M | 1,536.09M | 1,330.19M |
| EBITDA | 2,305.83M | 2,288.68M | 2,478.79M | 2,814.50M | 2,828.21M |
| Diluted EPS | 0.68 | 0.54 | 0.76 | 1.10 | 0.95 |
| Dividends Per Share | 0.17 | 0.16 | 0.22 | 0.30 | 0.30 |
| Total Assets | 16,798.25M | 19,678.17M | 20,232.43M | 21,693.96M | 23,266.05M |
| Total liabilities | 7,644.85M | 10,270.29M | 9,749.48M | 9,421.12M | 10,593.05M |
| Total equity | 9,027.75M | 9,269.99M | 10,332.44M | 12,105.18M | 12,481.23M |
| Operating cash flow | 1,252.51M | 1,800.55M | 1,560.33M | 2,254.67M | 1,912.28M |
Valuation Measures
| Mar 2019 | |
| PER | 10.80 |
| ROA | 6.04% |
| ROE | 11.05% |
| Operating margin | 9.65% |
| Profit margin | 6.79% |
Key executives
- Executive President & Representative Director: Hideki Kobori
- Director, Head-Information Technology & Finance: Yutaka Shibata
- General Manager-Research & Development: Hiroshi Shirai
- Head-Risk, Compliance, Legal & General Affairs: Nobuyuki Kakizawa
- Director & Executive Vice President: Hiroshi Yoshida
Shareholders
- Capital Research & Management Co. (World Investors) (8.2%)
- Nippon Life Insurance Co. (4.6%)
- Capital Research & Management Co. (Global Investors) (3.6%)
- Sumitomo Mitsui Trust Asset Management Co., Ltd. (3.2%)
- Nomura Asset Management Co., Ltd. (3.1%)
- Sumitomo Mitsui Financial Group, Inc. (2.5%)
- The Vanguard Group, Inc. (2.3%)
- Asahi Kasei Employee Stock Ownership Plan (2.3%)
- Daiwa Asset Management Co. Ltd. (1.5%)
- Mizuho Bank Pension Fund (1.4%)
Contact Details
- Website:http://www.asahi-kasei.co.jp
- Address: Hibiya Mitsui Tower, 1-1-2 Yuraku-cho, Tokyo, 100-0006, Japan
- Phone: +81.3.6699.3000
Related Companies
- Asahikasei Haus SSI Co. Ltd.
- Polypore KK
- Asahi-Schwebel Co. Ltd.
- Asahi Kasei Plastics America, Inc.
- Asahi Kasei Corporate Venture Capital
- Asahi Kasei Board Incentive Plan
- Asahi-Schewebel Co., Ltd.
- Asahi Tokyo Investment Trust Management Co., Ltd.
- Asahi Kasei Europe GmbH
- Asahi Kasei (China) Investment Co. Ltd.
- Kyokuyo Textile (Thailand) Co. Ltd.
- Asahi Kasei Synthetic Rubber Europe NV/SA
- Asahi Kasei Deutschland GmbH
- Asahi Kasei E-Materials Korea, Inc.
- Asahi Kasei Medical Trading (Korea) Co. Ltd.
- Asahi Kasei Tibbi Cihazlar Tic Ltd. Sti
- Asahi Kasei (Suzhou) Plastics Compound Co. Ltd.
- Asahi Kasei EMD Taiwan Corp.
- Asahikasei Plastics (Hong Kong) Co. Ltd.
- Asahi Kasei Fibers Italia SRL
- Asahikasei Plastics (America), Inc.
- Asahi Kasei POM (Zhangjiagang) Co. Ltd.
- ASAHI KASEI MICROZA (Hangzhou) Co. Ltd.
- Asahi Kasei Bioprocess Europe NV/SA
- Asahi Kasei Medical Trading Taiwan Co. Ltd.
- Asahi Kasei Microdevices Korea Corp.
- Asahi Kasei Microdevices (Shanghai) Co. Ltd.
- Asahi Kasei Fibers International (Shanghai) Co. Ltd.
- Asahi Kasei Electronics Materials Changshu Co. Ltd.
- Asahi Kasei Performance Chemicals Corp.
Competitors
- Sumitomo Chemical Co., Ltd.
- Eternal Materials Co., Ltd.
- Covestro AG
- LG Chem Ltd.
- Trinseo SA
- Celanese Corporation
- thyssenkrupp AG
- Fresenius Medical Care AG & Co. KGaA
- Green Seal Holding Ltd.
- Everspin Technologies, Inc.
- Shenzhen Capchem Technology Co., Ltd. Class A
- CytoSorbents Corporation
- Cirrus Logic, Inc.
- DMC Global Inc.
- Excelsior Medical Co., Ltd.
- Nephros, Inc.
- PledPharma AB
- Stryker Corporation
Copyright © 2019 FactSet Research Systems Inc. All rights reserved.
Last Updated on 11 Oct, 2019